PMDA drug package insert
スーグラ錠25mg
PMDA Prescription drug · アステラス製薬株式会社 · package insert Aug 28, 2025
Key facts
| Brand names | スーグラ錠25mg, スーグラ錠50mg |
|---|---|
| Nonproprietary names | イプラグリフロジン Ｌ－プロリン |
| Companies | 製造販売／アステラス製薬株式会社, 販売提携／寿製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 選択的SGLT2阻害剤 －糖尿病治療剤－ |
| Therapeutic category codes | 873969 |
| YJ codes | 3969018F1022, 3969018F2029 |
| Approval numbers | 22600AMX00009, 22600AMX00010 |
| Package insert edition | 第5版 |
| Package insert date | Aug 28, 2025 |
| PMDA document key | 800126_3969018F1022_1 |
| PMDA company code | 800126 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: